Antibiotice S.A. (BVB:ATB)
2.100
+0.005 (0.24%)
At close: May 18, 2026
Antibiotice Market Cap
Antibiotice has a market cap or net worth of 1.41 billion as of May 19, 2026. Its market cap has increased by 0.96% in one year.
Market Cap
1.41B
Enterprise Value
1.64B
Revenue
660.04M
Ranking
n/a
PE Ratio
27.23
Stock Price
2.10
Market Cap Chart
Since December 20, 2004, Antibiotice's market cap has increased from 202.01M to 1.41B, an increase of 597.91%. That is a compound annual growth rate of 9.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 18, 2026 | 1.41B | -14.29% |
| Dec 30, 2025 | 1.64B | -4.30% |
| Dec 30, 2024 | 1.72B | 83.51% |
| Dec 29, 2023 | 936.52M | 146.47% |
| Dec 30, 2022 | 379.98M | -6.60% |
| Dec 30, 2021 | 406.83M | 24.69% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aerostar | 1.90B |
| Fondul Proprietatea | 1.74B |
| Aquila Part Prod Com | 1.69B |
| Infinity Capital Investments | 1.67B |
| Sphera Franchise Group | 1.47B |
| Biofarm | 1.42B |
| Teraplast | 1.35B |
| Transilvania Investments Alliance | 1.21B |